Nicholas Adams - Bioquell Plc Group Chief Executive and Executive Director

Director

Mr. Nicholas M. T. Adams is Chief Executive, Executive Director of Bioquell PLC. He Joined the Board in May 1997 and was appointed Chief Executive in May 1998. Previously he was a Director of Corporationrationrate Finance at Barings, an investment bank, having spent nine years in Barings Corporationrationrate Finance Department both in the UK and continental Europe. He read chemistry at Durham University. since 1998.
Tenure 26 years
Phone44 1264 835 835
Webhttp://www.bioquellplc.com

Bioquell Plc Management Efficiency

The company has return on total asset (ROA) of 6.36 % which means that it generated a profit of $6.36 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on equity (ROE) of 12.0 %, meaning that it generated $12.0 on every $100 dollars invested by stockholders. Bioquell Plc's management efficiency ratios could be used to measure how well Bioquell Plc manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

DIRECTOR Age

James JonesNMI Holdings
69
William FerryDuluth Holdings
76
Douglas SkidmoreCincinnati Financial
55
John OsmonNMI Holdings
38
James OzanneNMI Holdings
74
Andrew RolfeJJill Inc
53
Andrew CleverlyCarters
75
Michael EckJJill Inc
57
David PulverCarters
78
Mark HippCarters
58
Linda ClementHolmesCincinnati Financial
55
Michael EmblerNMI Holdings
53
Richard NollCarters
62
Amy BrinkleyCarters
64
Thomas WhiddonCarters
66
Paul FultonCarters
82
John SchiffCincinnati Financial
71
Regina MuehlhauserNMI Holdings
69
David OsbornCincinnati Financial
57
William McMullenCincinnati Financial
57
Thomas SchiffCincinnati Financial
70
Bioquell plc designs, manufactures, and supplies bio-decontamination and containment equipment, and related products and services in the United Kingdom and internationally. The company was incorporated in 1925 and is headquartered in Andover, the United Kingdom. Bioquell plc operates under Medical Devices classification in USA and is traded on OTC Market. It employs 220 people. Bioquell Plc [BIQLF] is traded as part of a regulated electronic trading bulletin board offered by the NASD.

Management Performance

Bioquell Plc Leadership Team

Elected by the shareholders, the Bioquell Plc's board of directors comprises two types of representatives: Bioquell Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioquell. The board's role is to monitor Bioquell Plc's management team and ensure that shareholders' interests are well served. Bioquell Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioquell Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ian Johnson, Non-Executive Chairman of the Board
Nigel Keen, Independent Non-Executive Chairman of the Board
Nicholas Adams, Group Chief Executive and Executive Director
Christopher Mills, Non-Executive Director
Anthony Bourne, Independent Non-Executive Director
Georgina Pope, Company Secretary
Michael Roller, Group Finance Director, Director
Ian Carruthers, Independent Non-Executive Director
Simon Constantine, Independent Non-Executive Director

Bioquell Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc bb equity is not an easy task. Is Bioquell Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Bioquell Plc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioquell Plc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioquell Plc will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Consideration for investing in Bioquell OTC BB Equity

If you are still planning to invest in Bioquell Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bioquell Plc's history and understand the potential risks before investing.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital